Commentary: Iatrogenic cytomegaloviral retinitis following intravitreal steroid implantation

[...]diligent care in case selection assumes significance. [6] PCR results are not immune from false positivity as well as negativity and should be interpreted with caution. Since the duration of anti-inflammatory action of IO lasts for 3–6 months after injection, it is important to closely monitor...

Full description

Saved in:
Bibliographic Details
Published in:Indian journal of ophthalmology 2018-09, Vol.66 (9), p.1363-1364
Main Author: Murugan, S
Format: Article
Language:English
Subjects:
Antiviral agents
Care and treatment
Case Reports
Case studies
Cataracts
Complications and side effects
Cytomegalovirus
Dexamethasone
Diabetes
Diagnosis
Edema
Gangrene
Iatrogenesis
Infections
Ophthalmology
Retinal diseases
Retinitis
Risk factors
Transplants & implants
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c569a-6ab863b2574780f9bd01aeac29d2f37076d42218391605a085d4d98cc8b289713
container_end_page 1364
container_issue 9
container_start_page 1363
container_title Indian journal of ophthalmology
container_volume 66
creator Murugan, S
description [...]diligent care in case selection assumes significance. [6] PCR results are not immune from false positivity as well as negativity and should be interpreted with caution. Since the duration of anti-inflammatory action of IO lasts for 3–6 months after injection, it is important to closely monitor and add prophylactic antivirals in the maintenance dose straddling their action duration to prevent any viral reactivation. [...]removal of IO for all such cases is a controversial option worth considering, especially for severe Zone 1 cases, given the medicolegal significance.
doi_str_mv 10.4103/ijo.IJO_446_18
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_708bf1a71bad44428398a832198d2e24</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A551469440</galeid><doaj_id>oai_doaj_org_article_708bf1a71bad44428398a832198d2e24</doaj_id><sourcerecordid>A551469440</sourcerecordid><originalsourceid>FETCH-LOGICAL-c569a-6ab863b2574780f9bd01aeac29d2f37076d42218391605a085d4d98cc8b289713</originalsourceid><addsrcrecordid>eNp9ktuLEzEUhwdR3Lr66qMM-Dw1t5kkPgileKks7Iu-CSGTZGq6maRm0pb97z1r92JhlTwETr584Zz8quo1RnOGEX3nN2m--nqpGOsUFk-qGZZSNLQT8mk1QxThhnEqzqoX07RBiHIsxfPqDOqEY85m1Y9lGkcXi87X7-uVLjmtXfSmNtcljW6tQ9r7rEOdXfHRFz_VQwohHXxc1z6WrPe-ZAfAVFxO3tZ-3AYNvuJTfFk9G3SY3Kvb_bz6_unjt-WX5uLy82q5uGhM20nddLoXHe1JyxkXaJC9RVg7bYi0ZKAc8c4yQrCgEneo1Ui0llkpjBE9EZJjel6tjl6b9EZtsx-hHZW0V38KKa-VzsWb4BRHoh-w5rjXljFGQCq0oATmYokjDFwfjq7trh-dNe6myXAiPT2J_qdap73qMKYCtSB4eyvI6dfOTUVt0i5H6F8RJCmmnFD6QMGInfJxSCAzo5-MWrQtZp1kDAHVPELBDzl4OUU3eCif8PNHeFjWjd7874LJaZqyG-4bxUjdBExBwNRDwODCm7_Hc4_fJQqAxRE4pACRmK7C7uCyAvYqpsM_tArTjqq7KNLfMwXizw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2093137233</pqid></control><display><type>article</type><title>Commentary: Iatrogenic cytomegaloviral retinitis following intravitreal steroid implantation</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><creator>Murugan, S</creator><creatorcontrib>Murugan, S</creatorcontrib><description>[...]diligent care in case selection assumes significance. [6] PCR results are not immune from false positivity as well as negativity and should be interpreted with caution. Since the duration of anti-inflammatory action of IO lasts for 3–6 months after injection, it is important to closely monitor and add prophylactic antivirals in the maintenance dose straddling their action duration to prevent any viral reactivation. [...]removal of IO for all such cases is a controversial option worth considering, especially for severe Zone 1 cases, given the medicolegal significance.</description><identifier>ISSN: 0301-4738</identifier><identifier>EISSN: 1998-3689</identifier><identifier>DOI: 10.4103/ijo.IJO_446_18</identifier><identifier>PMID: 30127174</identifier><language>eng</language><publisher>India: Wolters Kluwer India Pvt. Ltd</publisher><subject>Antiviral agents ; Care and treatment ; Case Reports ; Case studies ; Cataracts ; Complications and side effects ; Cytomegalovirus ; Dexamethasone ; Diabetes ; Diagnosis ; Edema ; Gangrene ; Iatrogenesis ; Infections ; Ophthalmology ; Retinal diseases ; Retinitis ; Risk factors ; Transplants &amp; implants</subject><ispartof>Indian journal of ophthalmology, 2018-09, Vol.66 (9), p.1363-1364</ispartof><rights>COPYRIGHT 2018 Medknow Publications and Media Pvt. Ltd.</rights><rights>2018. This work is published under https://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright: © 2018 Indian Journal of Ophthalmology 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c569a-6ab863b2574780f9bd01aeac29d2f37076d42218391605a085d4d98cc8b289713</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113805/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2093137233?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,44566,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30127174$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Murugan, S</creatorcontrib><title>Commentary: Iatrogenic cytomegaloviral retinitis following intravitreal steroid implantation</title><title>Indian journal of ophthalmology</title><addtitle>Indian J Ophthalmol</addtitle><description>[...]diligent care in case selection assumes significance. [6] PCR results are not immune from false positivity as well as negativity and should be interpreted with caution. Since the duration of anti-inflammatory action of IO lasts for 3–6 months after injection, it is important to closely monitor and add prophylactic antivirals in the maintenance dose straddling their action duration to prevent any viral reactivation. [...]removal of IO for all such cases is a controversial option worth considering, especially for severe Zone 1 cases, given the medicolegal significance.</description><subject>Antiviral agents</subject><subject>Care and treatment</subject><subject>Case Reports</subject><subject>Case studies</subject><subject>Cataracts</subject><subject>Complications and side effects</subject><subject>Cytomegalovirus</subject><subject>Dexamethasone</subject><subject>Diabetes</subject><subject>Diagnosis</subject><subject>Edema</subject><subject>Gangrene</subject><subject>Iatrogenesis</subject><subject>Infections</subject><subject>Ophthalmology</subject><subject>Retinal diseases</subject><subject>Retinitis</subject><subject>Risk factors</subject><subject>Transplants &amp; implants</subject><issn>0301-4738</issn><issn>1998-3689</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9ktuLEzEUhwdR3Lr66qMM-Dw1t5kkPgileKks7Iu-CSGTZGq6maRm0pb97z1r92JhlTwETr584Zz8quo1RnOGEX3nN2m--nqpGOsUFk-qGZZSNLQT8mk1QxThhnEqzqoX07RBiHIsxfPqDOqEY85m1Y9lGkcXi87X7-uVLjmtXfSmNtcljW6tQ9r7rEOdXfHRFz_VQwohHXxc1z6WrPe-ZAfAVFxO3tZ-3AYNvuJTfFk9G3SY3Kvb_bz6_unjt-WX5uLy82q5uGhM20nddLoXHe1JyxkXaJC9RVg7bYi0ZKAc8c4yQrCgEneo1Ui0llkpjBE9EZJjel6tjl6b9EZtsx-hHZW0V38KKa-VzsWb4BRHoh-w5rjXljFGQCq0oATmYokjDFwfjq7trh-dNe6myXAiPT2J_qdap73qMKYCtSB4eyvI6dfOTUVt0i5H6F8RJCmmnFD6QMGInfJxSCAzo5-MWrQtZp1kDAHVPELBDzl4OUU3eCif8PNHeFjWjd7874LJaZqyG-4bxUjdBExBwNRDwODCm7_Hc4_fJQqAxRE4pACRmK7C7uCyAvYqpsM_tArTjqq7KNLfMwXizw</recordid><startdate>20180901</startdate><enddate>20180901</enddate><creator>Murugan, S</creator><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt Ltd</general><general>Wolters Kluwer Medknow Publications</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20180901</creationdate><title>Commentary: Iatrogenic cytomegaloviral retinitis following intravitreal steroid implantation</title><author>Murugan, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c569a-6ab863b2574780f9bd01aeac29d2f37076d42218391605a085d4d98cc8b289713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antiviral agents</topic><topic>Care and treatment</topic><topic>Case Reports</topic><topic>Case studies</topic><topic>Cataracts</topic><topic>Complications and side effects</topic><topic>Cytomegalovirus</topic><topic>Dexamethasone</topic><topic>Diabetes</topic><topic>Diagnosis</topic><topic>Edema</topic><topic>Gangrene</topic><topic>Iatrogenesis</topic><topic>Infections</topic><topic>Ophthalmology</topic><topic>Retinal diseases</topic><topic>Retinitis</topic><topic>Risk factors</topic><topic>Transplants &amp; implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murugan, S</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Indian journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murugan, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Commentary: Iatrogenic cytomegaloviral retinitis following intravitreal steroid implantation</atitle><jtitle>Indian journal of ophthalmology</jtitle><addtitle>Indian J Ophthalmol</addtitle><date>2018-09-01</date><risdate>2018</risdate><volume>66</volume><issue>9</issue><spage>1363</spage><epage>1364</epage><pages>1363-1364</pages><issn>0301-4738</issn><eissn>1998-3689</eissn><abstract>[...]diligent care in case selection assumes significance. [6] PCR results are not immune from false positivity as well as negativity and should be interpreted with caution. Since the duration of anti-inflammatory action of IO lasts for 3–6 months after injection, it is important to closely monitor and add prophylactic antivirals in the maintenance dose straddling their action duration to prevent any viral reactivation. [...]removal of IO for all such cases is a controversial option worth considering, especially for severe Zone 1 cases, given the medicolegal significance.</abstract><cop>India</cop><pub>Wolters Kluwer India Pvt. Ltd</pub><pmid>30127174</pmid><doi>10.4103/ijo.IJO_446_18</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0301-4738
ispartof Indian journal of ophthalmology, 2018-09, Vol.66 (9), p.1363-1364
issn 0301-4738
1998-3689
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_708bf1a71bad44428398a832198d2e24
source Open Access: PubMed Central; Publicly Available Content Database
subjects Antiviral agents
Care and treatment
Case Reports
Case studies
Cataracts
Complications and side effects
Cytomegalovirus
Dexamethasone
Diabetes
Diagnosis
Edema
Gangrene
Iatrogenesis
Infections
Ophthalmology
Retinal diseases
Retinitis
Risk factors
Transplants & implants
title Commentary: Iatrogenic cytomegaloviral retinitis following intravitreal steroid implantation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T07%3A58%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Commentary:%20Iatrogenic%20cytomegaloviral%20retinitis%20following%20intravitreal%20steroid%20implantation&rft.jtitle=Indian%20journal%20of%20ophthalmology&rft.au=Murugan,%20S&rft.date=2018-09-01&rft.volume=66&rft.issue=9&rft.spage=1363&rft.epage=1364&rft.pages=1363-1364&rft.issn=0301-4738&rft.eissn=1998-3689&rft_id=info:doi/10.4103/ijo.IJO_446_18&rft_dat=%3Cgale_doaj_%3EA551469440%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c569a-6ab863b2574780f9bd01aeac29d2f37076d42218391605a085d4d98cc8b289713%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2093137233&rft_id=info:pmid/30127174&rft_galeid=A551469440&rfr_iscdi=true